journal article·2014-08-26Open access

Acceleration of Tissue Plasminogen Activator-Mediated Thrombolysis by Magnetically Powered Nanomotors

Rui Cheng, Weijie Huang, Lijie Huang, Bo Yang, Leidong Mao, Kunlin Jin, Qichuan ZhuGe, Yiping Zhao

ACS Nano· Volume 8· Issue 8

Abstract

Dose control and effectiveness promotion of tissue plasminogen activator (t-PA) for thrombolysis are vitally important to alleviate serious side effects such as hemorrhage in stroke treatments. In order to increase the effectiveness and reduce the risk of stroke treatment, we use rotating magnetic nanomotors to enhance the mass transport of t-PA molecules at the blood clot interface for local ischemic stroke therapy. The in vitro experiments demonstrate that, when combined with magnetically activated nanomotors, the thrombolysis speed of low-concentration t-PA (50 μg mL(-1)) can be enhanced up to 2-fold, to the maximum lysis speed at high t-PA concentration. Based on the convection enhanced transport theory due to rotating magnetic nanomotors, a theoretical model is proposed and predicts the experimental results reasonably well. The validity and efficiency of this enhanced treatment has been demonstrated in a rat embolic model.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology and Neuroscience, Institute for Alzheimer’s Disease and Aging Research, University of North Texas Health Science Center, Fort Worth, Texas 76107, United States

Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China

Department of Mechanical and Aerospace Engineering, University of Texas, Arlington, Texas 76019, United States

Funding

Division of Electrical, Communications and Cyber Systems · National Institute of Neurological Disorders and Stroke

References (37)

Show source-provided references
1. Laverdure A. M. · Indoor Built Environ. · 2001 · 10 · 30610.1177/1420326X0101000505 ↗
2. Alexandrov A. V. · N. Engl. J. Med. · 2004 · 351 · 217010.1056/NEJMoa041175 ↗
3. Mohr J. P. · JAMA · 2000 · 283 · 118910.1001/jama.283.9.1189 ↗
4. Adams H. P. · Stroke · 2007 · 38 · 165510.1161/STROKEAHA.107.181486 ↗
5. Rosengart A. J. · Stroke · 2004 · 35 · 299
6. Abdalla A. · Int. J. Pharm. · 2009 · 367 · 2910.1016/j.ijpharm.2008.09.014 ↗
7. Kaminski M. D. · Eur. J. Pharm. Sci. · 2008 · 35 · 9610.1016/j.ejps.2008.06.012 ↗
8. Chen A. P. · Cryst. Growth Des. · 2011 · 11 · 540510.1021/cg200999s ↗
9. Myerson J. · J. Thromb. Haemostasis · 2011 · 9 · 129210.1111/j.1538-7836.2011.04339.x ↗
10. Korin N. · Science · 2012 · 337 · 73810.1126/science.1217815 ↗
11. Marsh J. N. · Nanomedicine · 2007 · 2 · 53310.2217/17435889.2.4.533 ↗
12. Adams H. P. · Circulation · 2007 · 115 · E47810.1161/CIRCULATIONAHA.107.181486 ↗
13. del Zoppo G. J. · Stroke · 2009 · 40 · 294510.1161/STROKEAHA.109.192535 ↗
14. Feldschuh J. · Circulation · 1977 · 56 · 60510.1161/01.CIR.56.4.605 ↗
15. Seifried E. · Thromb. Haemostasis · 1989 · 61 · 49710.1055/s-0038-1646622 ↗
16. Tanswell P. · Arzneimittelforschung · 1991 · 41 · 1310
17. Yeo L. L. · JAMA Neurol. · 2013 · 70 · 35310.1001/2013.jamaneurol.547 ↗
18. Riedel C. H. · Stroke · 2011 · 42 · 177510.1161/STROKEAHA.110.609693 ↗
19. Wu J. H. · Thromb. Haemostasis · 1994 · 72 · 10510.1055/s-0038-1648820 ↗
20. Diamond S. L. · Biophys. J. · 1993 · 65 · 262210.1016/S0006-3495(93)81314-6 ↗
21. Anand S. · Biotechnol. Bioeng. · 1995 · 48 · 8910.1002/bit.260480203 ↗
22. Garber P. J. · Can. J. Cardiol. · 1995 · 11 · 30
23. Prewitt R. M. · J. Am. Coll. Cardiol. · 1992 · 20 · 162610.1016/0735-1097(92)90459-Z ↗
24. Kumbasar S. D. · Int. J. Cardiol. · 1998 · 65 · 16910.1016/S0167-5273(98)00121-1 ↗
25. He Y. · Small · 2007 · 3 · 15310.1002/smll.200600375 ↗
26. Kaplan A. P. · Thromb. Haemostasis · 1978 · 39 · 26310.1055/s-0038-1646687 ↗
27. Collen D. · J. Cell. Biochem. · 1987 · 33 · 7710.1002/jcb.240330202 ↗
28. Collen D. · Therapie · 1988 · 43 · 69
29. Cesarman-Maus G. · Br. J. Hamaetol. · 2005 · 129 · 30710.1111/j.1365-2141.2005.05444.x ↗
30. Collen D. · Arterioscler., Thromb., Vasc. Biol. · 2009 · 29 · 115110.1161/ATVBAHA.108.179655 ↗
31. Calef D. F. · Annu. Rev. Phys. Chem. · 1983 · 34 · 49310.1146/annurev.pc.34.100183.002425 ↗
32. McCarty P. · Phys. Rev. A · 1988 · 37 · 211210.1103/PhysRevA.37.2112 ↗
33. Rosenbluth M. N. · Phys. Fluids · 1987 · 30 · 263610.1063/1.866107 ↗
34. Sagues F. · Phys. Rev. A · 1986 · 34 · 413610.1103/PhysRevA.34.4136 ↗
35. Petousis I. · Lab Chip · 2007 · 7 · 174610.1039/b713735b ↗
36. Radomski A. · Br. J. Pharmacol. · 2005 · 146 · 88210.1038/sj.bjp.0706386 ↗
37. Zhao Y. P. · Nano Lett. · 2002 · 2 · 35110.1021/nl0157041 ↗